Ding-Liang Zhu Selected Research

hirulog-like peptide

1/2010	Effect of hirulog-like peptide on balloon catheter injury-induced neointimal formation in femoral arteries of minipigs and relationship with inflammatory mediators.
10/2007	Pharmacokinetics and pharmacology of hirulog-like peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ding-Liang Zhu Research Topics

Disease

12	Inflammation (Inflammations) 01/2019 - 01/2012
11	Hypertension (High Blood Pressure) 01/2018 - 07/2007
7	Vascular System Injuries 01/2017 - 10/2007
7	Essential Hypertension 07/2015 - 11/2003
6	Fibrosis (Cirrhosis) 01/2019 - 09/2013
4	Hypertrophy 01/2019 - 01/2011
3	Vascular Diseases (Vascular Disease) 01/2020 - 01/2012
2	Neointima 01/2020 - 09/2012
2	Adenoma (Adenomas) 01/2017 - 03/2015
2	Atherosclerosis 01/2016 - 11/2009
1	Obesity 01/2018
1	Vascular Calcification 01/2017
1	Chronic Renal Insufficiency 06/2014
1	Cardiomegaly (Heart Hypertrophy) 09/2013
1	Heart Failure 01/2013
1	Hyperplasia 09/2011
1	Hemorrhage 01/2010
1	Atherosclerotic Plaque (Atheroma) 11/2009
1	Vascular Ring 05/2009
1	Diabetic Nephropathies (Diabetic Nephropathy) 02/2008
1	Albuminuria 02/2008
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2007

Drug/Important Bio-Agent (IBA)

8	Angiotensin IIIBA 01/2019 - 01/2012
5	CollagenIBA 01/2019 - 09/2011
5	Angiotensin-Converting Enzyme 2IBA 01/2016 - 01/2011
4	AldosteroneIBA 01/2017 - 12/2012
3	Complement System Proteins (Complement)IBA 01/2018 - 03/2015
3	OsteopontinIBA 01/2017 - 09/2012
3	Irbesartan FDA LinkGeneric 12/2016 - 01/2012
3	SaltsIBA 03/2016 - 04/2013
3	Apolipoproteins E (ApoE)IBA 01/2016 - 11/2009
3	ApolipoproteinsIBA 01/2016 - 11/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 09/2012
2	CytokinesIBA 01/2018 - 12/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 05/2009
2	ApelinIBA 12/2016 - 06/2009
2	Fibronectins (Fibronectin)IBA 10/2016 - 09/2013
2	Desoxycorticosterone (Deoxycorticosterone)IBA 03/2016 - 03/2015
2	Acetates (Acetic Acid Esters)FDA Link 03/2016 - 03/2015
2	Telmisartan (Micardis)FDA Link 11/2013 - 01/2011
2	Mitogen-Activated Protein Kinase 3IBA 09/2013 - 01/2011
2	C-Reactive ProteinIBA 10/2012 - 02/2007
2	Peptides (Polypeptides)IBA 09/2012 - 10/2007
2	Profilins (Profilin)IBA 01/2012 - 01/2011
2	AngiotensinsIBA 01/2012 - 01/2011
2	hirulog-like peptideIBA 01/2010 - 10/2007
1	Oxygen (Dioxygen)IBA 01/2020
1	Ranibizumab (Lucentis)FDA Link 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2019
1	Anaphylatoxin C5a ReceptorIBA 01/2018
1	LeptinIBA 01/2018
1	Sirtuin 3IBA 01/2018
1	Complement C3a (Complement 3a)IBA 01/2018
1	AdiponectinIBA 01/2017
1	MineralsIBA 01/2017
1	AdipokinesIBA 01/2017
1	Glycoproteins (Glycoprotein)IBA 01/2017
1	apelin-13 peptideIBA 12/2016
1	salicylhydroxamic acid (SHAM)IBA 12/2016
1	3- (2- ethylphenoxy)- 1- (1,2,3,4- tetrahydronaphth- 1- ylamino)- 2- propanol oxalateIBA 03/2016
1	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	nephrinIBA 08/2015
1	Superoxides (Superoxide)IBA 08/2015
1	ProstaglandinsIBA 07/2015
1	Desoxycorticosterone Acetate (DOCA)FDA Link 03/2015
1	DNA (Deoxyribonucleic Acid)IBA 03/2015
1	Complement C5a (Complement 5a)IBA 03/2015
1	Biomarkers (Surrogate Marker)IBA 06/2014
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 11/2013
1	hydrochlorothiazide drug combination telmisartanIBA 11/2013
1	Atrial Natriuretic Factor (ANF)IBA 09/2013
1	Connective Tissue Growth FactorIBA 09/2013
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 09/2013
1	AntioxidantsIBA 04/2013
1	Bisoprolol (Concor)FDA LinkGeneric 01/2013
1	Matrix Metalloproteinases (MMPs)IBA 01/2013
1	Atenolol (Tenormin)FDA LinkGeneric 01/2013
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2012
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2012
1	JNK Mitogen-Activated Protein KinasesIBA 01/2011
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2011
1	Heparin (Liquaemin)FDA LinkGeneric 01/2010
1	bivalirudin (Angiomax)FDA Link 01/2010
1	P-SelectinIBA 01/2010
1	fasudil (AT 877)IBA 11/2009
1	Phosphotransferases (Kinase)IBA 11/2009
1	rho-Associated KinasesIBA 11/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2009
1	Acetylcysteine (Siran)FDA LinkGeneric 05/2009
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 05/2009
1	MicroRNAs (MicroRNA)IBA 08/2008
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2008
1	Thrombin FDA Link 10/2007
1	Cytochrome P-450 CYP2J2 (CYP2J2)IBA 07/2007

Therapy/Procedure

2	Therapeutics 12/2016 - 04/2013
1	Denervation 10/2016
1	Catheters 01/2010